TREATMENT OF T-CELL LYMPHOMA IN DOGS

摘要

General statistics for survival of canine lymphoma patients can be derived from reports of the efficacy of different chemotherapy protocols. Studies have evaluated multiple factors in an effort to provide a prognosis for the individual patient; currently lymphoma is one of the best characterized of canine tumors with regards to prognostic factors. It is clear that good clinical staging and ancillary laboratory testing provide important prognostic information. In addition to the extent of disease (stage) and physical "wellness" of the patient (substage), the most consistently important prognostic factor has been identification of the T-cell phenotype.